TrialScientific reports2023

An open-label study evaluating the safety and efficacy of budesonide in patients with IgA nephropathy at high risk of progression.

Bogdan Obrișcă et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.